Evidence map›Paper›PMID 39108718›Full record

ArticleiScience2024

Impaired phase separation and nucleolar functions in hiPSC models of

Wei Zhang, Minjie Zhang, Li Ma, Supawadee Jariyasakulroj, Qing Chang, Ziying Lin, Zhipeng Lu, Jian-Fu Chen

Abstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wei ZhangCenter for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
Minjie ZhangDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Li MaCenter for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
Supawadee JariyasakulrojCenter for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
Qing ChangCenter for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
Ziying LinCenter for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.
Zhipeng LuDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Jian-Fu ChenCenter for Craniofacial Molecular Biology, University of Southern California, Los Angeles, CA 90033, USA.

Funding

DOCTORAL AND POST-DOCTORAL TRAINING IN CRANIOFACIAL BIOLOGYT90DE021982 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PAINE, MICHAEL LANSDELL · 2011 to 2025
$6.2M
High Throughput Determination of RNA 3D Structures and Dynamics in VivoR35GM143068 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LU, ZHIPENG · 2021 to 2025
$2.1M
Selective neurovascular regulation by a vascular dementia-related noncoding RNA Snord118R21AG070681 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHEN, JIANFU · 2022 to 2022
$467k
Neurovascular functions of a small RNA Snord118-mediated ribosome biogenesisR21AG075665 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHEN, JIANFU · 2022 to 2022
$454k
NIA NIH HHS R21 AG070681NIA NIH HHS R21 AG075665NIDCR NIH HHS T90 DE021982NIGMS NIH HHS R35 GM143068
6 · The paper itself

Abstract

Ribosomopathies arise from the disruptions in ribosome biogenesis within the nucleolus, which is organized via liquid-liquid phase separation (LLPS). The roles of LLPS in ribosomopathies remain poorly understood. Here, we generated human induced pluripotent stem cell (hiPSC) models of ribosomopathy caused by mutations in small nucleolar RNA (snoRNA) gene SNORD118. Mutant hiPSC-derived neural progenitor cells (NPCs) or neural crest cells (NCCs) exhibited ribosomopathy hallmark cellular defects resulting in reduced organoid growth, recapitulating developmental delay in patients. SNORD118 mutations in NPCs disrupted nucleolar morphology and LLPS properties coupled with impaired ribosome biogenesis and a translational downregulation of fibrillarin (FBL), the key LLPS effector acting via the intrinsically disordered region (IDR) motif. IDR-depleted FBL failed to rescue NPC defects, whereas a chimeric FBL with swapped IDR motif from an unrelated protein mitigated ribosomopathy and organoid growth defects. Thus, SNORD118 human iPSC models revealed aberrant phase separation and nucleolar functions as potential pathogenic mechanisms in ribosomopathies.

Indexed as

Biological sciencesCell biologyNatural sciencesStem cell research

Identifiers

PMID39108718
PMCPMC11300908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.